Clinical relevance: This study investigates the effect of an initial specimen diversion device on the rate of 19 culture contamination in hospitalized patients. It finds that the device is associated with a significant reduction in 20 contamination. This intervention may result in a reduction in costs, antibiotic use and duration of hospitalization. 21
Abstract 24
False positive blood cultures result from contamination, consuming microbiological laboratory resources and 25 causing unnecessary antibiotic treatment and lengthened hospitalizations. Skin sterilization has been shown to 26 reduce contamination; however, bacteria do not only colonize the surface of human skin, but are also found in 27 deeper tissues, requiring additional techniques to reduce contamination. An initial specimen diversion device 28 diverts the initial 1-2 ml of blood so as to remove any potentially contaminated skin plug, thus potentially further 29 reducing culture contamination. The device has been associated with a reduction in culture contamination over 30 short study periods in certain populations. However, more study is needed to understand whether the effect 31 continues over longer periods of time and in hospitalized patients. Thus, in this prospective, controlled pragmatic 32 study, cultures were obtained from hospitalized patients using the initial specimen diversion device, with cultures 33 taken using standard methods serving as control. In total, 671 blood cultures were obtained: 207 cultures were 34 taken using an initial specimen diversion device, with 2 (1.0%) contaminated cultures and 464 cultures were taken 35 Introduction 43 Bloodstream infections cause significant morbidity and mortality and their prompt identification is an essential 44 part of modern medicine. Blood cultures, first described in the latter part of the nineteenth century 1 , are an 45 essential element of the diagnosis and treatment of patients with such infections. However, as with all medical 46 testing, false positive results occur and these result in delays in diagnosis, inappropriate treatment and 47 significantly added expenses. 2,3 False positive results in blood cultures have been described for as long as there 48 have been such cultures and are primarily due to contaminants. 1, 2 It has been estimated that up to 50% of positive 49 blood cultures represent contamination. 2,3 These false positive cultures, at the microbiological laboratory level, 50 require significant additional resources for workup. In addition, and perhaps more importantly, these false positive 51 cultures may result in unnecessary antibiotic treatment as well as additional hospitalization days, causing needless 52 harm to patients. All this together results an estimated additional cost of $4,385-$8,720 per false positive blood 53 culture in the United States. 3-6 54
Various methods have been implemented in order to reduce blood culture contaminants. Overall, combined 55 interventions have proven effective in attenuating blood culture contamination and many institutions have 56 successfully reducing blood culture contamination to the currently recommended rate of less than 2-3%, with the 57 highest achieving institutions having rates as little as 0.6%. 4,7 However, it has been shown that the bacteria which 58 colonize the human skin are found not only on the surface but in fact in deeper tissues as well. It has further been 59
shown that these bacteria cannot be completely removed even under ideal conditions. 7,8 Thus zero or near zero 60 blood culture contamination using current methods may be impossible, even with perfect technique. As such, it is 61 reasonable to seek techniques beyond skin sterilization and improved adherence in order to further reduce the rate 62 of blood culture contamination. 63
Recently, a new device was developed that diverts the initial 1-2ml blood so as to remove any potential skin 64 plug with contaminants from entering the blood culture bottle. The SteriPath device (Magnolia Medical 65 Technologies, Seattle, WA) is a closed-system, sterile blood collection system that diverts 1-2mL of the initial 66 venipuncture blood into an isolated diversion chamber and then allows venous blood to flow into culture bottles. culture contamination without reducing sensitivity to true blood stream infection. A recent study showed the 69 utility of this device in an emergency room setting. 9 However, this study was conducted over a short period of 70 time, did not evaluate in-patients and used paired cultures, rather than a pragmatic design. Thus this study was 71 designed as a pragmatic trial to evaluate the use of the diversion device in reducing blood culture contamination 72 over the period of approximately 6 months in an in-patient population. During study period, as is standard practice in our institution, blood cultures were, in preference, taken by 83 phlebotomy teams using venipuncture, two interventions that have been shown in multiple studies to reduce the 84 rate of blood culture contamination. 2, 6 The remainder of cultures were taken mostly by resident physicians. Prior 85 to study initiation a feedback mechanism was initiated in our institution in order to reduce contamination prior to 86 the study (unpublished data) and reduce observer effect during the study period. 87
During the course of the study, in a convenience sample of patients in one medical department, blood cultures 88 were obtained using the initial specimen diversion device, either via an integrated needle, or in cases of 89 intravenous line placement, by attaching the device to the newly placed intravenous catheter. The control group 90 consisted of blood cultures taken in the department using standard devices -Vacuette Holdex ® (Grenier Bio-One, 91
Kremsmünster, Austria) attached to either a scalp vein set or to an intravenous catheter. In either method, blood 92 was inoculated into BD BACTEC™ Plus Aerobic/F in addition to Plus Anaerobic/F culture bottles (BACTEC, 93
Franklin Lakes, NJ). An automated blood culture system, BD BACTEC FX (BACTEC) was used to process the 94 blood cultures. Relevant characteristics of the blood culture, including date of culture and site of blood collection, 95 were recorded. Isolates were identified using MALDI-TOF (Vitek MS, bioMérieux) and/or standard biochemical 96 methods. 97
Blood culture contamination was identified by microbiological criteriagrowth of coagulase-negative 98 staphylococci (CNS), corynebacteria, micrococci or alpha-hemolytic streptococci. Cultures could be reclassified 99 as true infections if such an organism was isolated from multiple blood cultures obtained by different 100 venipuncture. It should be noted that given the high sensitivity and short time to positivity of modern blood 101 culture systems 10 , time to positivity is not an effective method of identifying culture contaminants. If a single 102 blood culture showed growth of true infection and contaminant organisms, it was included in both categories. 103
During the first month of the study observers provided technical support to ensure proper use of the device by 104 the userswhether phlebotomists or physicians. The observers did not provide direct assistance in blood culture 105 collection. For the remaining five months of the study the device was used without observer presence. During the 106 entire period, blood cultures were collected according to the clinical discretion of the treating physician.
Results

116
In the 6 months of the study period, 671 blood cultures were obtained in the study department. Of these, 207 117 cultures were recorded to have been taken using the initial specimen diversion device; this population served as 118 the study group. In 464 cultures, use of the device was not recorded; this population served as the control group. A 119 significant difference in age was found between the control group and the study group (74±1.4 versus 77±2.1, 120 respectively, p<0.004). Otherwise no differences between the groups were noted (Table 1) . 121
Of the 464 cultures in the control group, 68 (14.7%) were positive for bacterial growth. Of those positive 122 cultures, 24 were defined as contaminants, thus resulting in a contamination rate of 5.2%. In the study group, 207 123 blood cultures were obtained. Of these, 18 (8.7%) were positive for bacterial growth. Of these positive cultures, 2 124 were defined as contaminants, thus resulting in a contamination rate of 1.0% in the study group (p<0.008 for the 125 difference between the groups). With the exception of a single culture in the control group which grew 126 importantly, these false positive cultures result in unnecessary antibiotic treatment as well as excessive 140 hospitalization days, causing needless harm to patients. All this together results in substantial additional costs per 141 false positive blood culture. 3-6 142 In this study, we investigated the efficacy of an initial specimen diversion device in reducing the rate of blood 143 culture contamination. We found that the device was associated with a reduction in blood culture contamination 144 with a 5.2% (24 out of 464 cultures) contamination rate in the control group and a 1.0% (2 out of 207 cultures) 145 contamination in the study group (p<0.008). These results are consistent with those obtained in a recent study 146 performed in an emergency room population. 9 In our study, the control group was noted to be younger than the 147 study group. 148
This study suggests that use of an initial specimen diversion device can effectively reduce culture 149 contamination among hospitalized patients without impacting the rate of true positive cultures. Furthermore, this 150 reduction can be maintained over a relatively extended period of time. 151
The study has several limitations. First, though this study was controlled, a pragmatic design using a 152 convenience sample, rather than a randomized control, was employed. Such a study is limited in controlling for 153 confounders related to selection of sample. Indeed, the study population was older than that of the control, though 154 no other significant differences were noted (Table 1) . Additionally, this study was a single center study with a 155 relatively small study population. As such, results should be interpreted cautiously. 156
In conclusion, this study found that use of an initial specimen diversion device was associated with a reduction 157 in blood culture contamination in hospitalized patients over a six month periodfrom 5.2% (24/464) in the 158 control group to 1.0% (2/207 -p<0.008) in the study groupwithout a concomitant reduction in true positive 159 cultures. This is an intervention that can result in a reduction in costs, unnecessary antibiotic use and duration of 160 hospitalization. 161
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